Timothy Tyson, CEO and President at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), sold 300 shares at $16.47 ($5K) on 2007-05-07, disclosed to the SEC on 2007-06-06.
Open-market sale of $5k VRX by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| SYRS | BUY | 2022-10-03 | $106K | — | Filing → |
| PrivateIcagen, Inc. | BUY |
| 2018-01-02 |
| $8K |
| — |
| Filing → |